Beacon Investment Advisory Services Inc. Has $30.29 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Beacon Investment Advisory Services Inc. reduced its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 9.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,756 shares of the medical instruments supplier’s stock after selling 2,527 shares during the quarter. Mettler-Toledo International accounts for approximately 1.3% of Beacon Investment Advisory Services Inc.’s holdings, making the stock its 24th biggest position. Beacon Investment Advisory Services Inc. owned 0.12% of Mettler-Toledo International worth $30,293,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of MTD. State Street Corp raised its position in Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares during the period. Barclays PLC raised its holdings in shares of Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after buying an additional 19,609 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares during the last quarter. Finally, Loomis Sayles & Co. L P grew its holdings in Mettler-Toledo International by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after acquiring an additional 3,644 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Analyst Ratings Changes

MTD has been the topic of a number of research reports. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company decreased their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Robert W. Baird decreased their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Finally, Wolfe Research started coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $1,351.25.

Insider Buying and Selling

In related news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,324.45 on Thursday. Mettler-Toledo International Inc. has a 52-week low of $1,133.46 and a 52-week high of $1,546.93. The stock has a market cap of $27.95 billion, a P/E ratio of 35.71, a P/E/G ratio of 4.19 and a beta of 1.12. The firm has a 50 day moving average price of $1,245.04 and a 200 day moving average price of $1,343.30.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.